Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $585.43 | 37 | 87.1% |
| Education | $86.49 | 1 | 12.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $242.07 | 10 | $0 (2021) |
| ABBVIE INC. | $114.49 | 7 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $74.35 | 5 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $67.16 | 5 | $0 (2021) |
| Otsuka America Pharmaceutical, Inc. | $46.85 | 3 | $0 (2021) |
| Alkermes, Inc. | $33.33 | 2 | $0 (2021) |
| Lundbeck LLC | $32.18 | 2 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.71 | 1 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.77 | 1 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $14.49 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $118.88 | 7 | ABBVIE INC. ($69.91) |
| 2021 | $553.04 | 31 | Teva Pharmaceuticals USA, Inc. ($242.07) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/29/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Central Nervous System | ||||||
| 06/10/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Neuroscience | ||||||
| 05/10/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Central Nervous System | ||||||
| 04/19/2021 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: PSYCHIATRY | ||||||
| 04/12/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Central Nervous System | ||||||
| 04/08/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Central Nervous System | ||||||
| 04/06/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: PSYCHIATRY | ||||||
| 03/25/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: NEUROLOGY | ||||||
| 03/18/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Neuroscience | ||||||
| 03/11/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: PSYCHIATRY | ||||||
| 03/02/2021 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Central Nervous System | ||||||
| 02/11/2021 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: PSYCHIATRY | ||||||
| 01/14/2021 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 44 | 435 | $59,825 | $21,882 |
| 2022 | 3 | 55 | 313 | $38,775 | $18,369 |
| 2021 | 4 | 194 | 388 | $41,148 | $22,218 |
| 2020 | 2 | 185 | 330 | $25,735 | $8,840 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 218 | $32,700 | $13,413 | 41.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 23 | 217 | $27,125 | $8,469 | 31.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 155 | $21,450 | $11,087 | 51.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 23 | 147 | $15,125 | $6,337 | 41.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,200 | $944.32 | 42.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 166 | $18,855 | $11,273 | 59.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 65 | 102 | $11,274 | $5,714 | 50.7% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 16 | 55 | $4,125 | $2,540 | 61.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $3,200 | $1,698 | 53.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 20 | 25 | $1,880 | $602.17 | 32.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 24 | $1,814 | $391.60 | 21.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 97 | 220 | $16,540 | $6,351 | 38.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 64 | 83 | $6,212 | $1,445 | 23.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 24 | 27 | $2,983 | $1,044 | 35.0% |
About Colby Ponder
Colby Ponder is a Psychiatric/Mental Health healthcare provider based in Houston, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/22/2019. The National Provider Identifier (NPI) number assigned to this provider is 1023572294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Colby Ponder has received a total of $671.92 in payments from pharmaceutical and medical device companies, with $118.88 received in 2024. These payments were reported across 38 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($585.43).
As a Medicare-enrolled provider, Ponder has provided services to 478 Medicare beneficiaries, totaling 1,466 services with total Medicare billing of $71,309. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Houston, MS
- Active Since 01/22/2019
- Last Updated 02/13/2023
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1023572294
Products in Payments
- AUSTEDO (Drug) $155.58
- VRAYLAR (Drug) $114.49
- INVEGA SUSTENNA (Drug) $74.35
- ABILIFY MAINTENA (Drug) $67.89
- INGREZZA (Drug) $67.16
- ARISTADA (Drug) $33.33
- CAPLYTA (Drug) $29.29
- TRINTELLIX (Drug) $17.71
- Qelbree (Drug) $14.49
- REXULTI (Drug) $11.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Houston
Natalie Tellez, Aprn, Pmhnp-Bc, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $393,491
Britney Pridgen, Np, NP
Psychiatric/Mental Health — Payments: $50,170
Ms. Melissa Rivera, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $19,256
Mrs. Linzi Leighton, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $12,884
Mrs. Jennifer Robinson, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $9,949
Samantha Sharpe, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $9,886